Chromosome Microarray (CMA) Detection (3) - CapitalBio Technology Co., Ltd.

Testing Content

Detection of 23 pairs of chromosomal aneuploidy and whole genome chromosomal abnormalities greater than 100kb.

Testing Method

Sample Requirements

Venous Blood: Collect 4mL, store at 2-8°C. Transport with biological ice packs (2-8°C) within 72 hours. Use an EDTA anticoagulant tube.

Reporting Cycle

10 working days

Clinical Application Overview

Assess chromosomal abnormalities and investigate the genetic causes of recurrent miscarriage and infertility.

PREV: Chromosome Microarray (CMA) Detection 2.0 (4)

NEXT: Chromosome Microarray (CMA) Detection

Related IVD Products

Related News Of IVD Technology

Working Principle of Deep Resolution DNA Microarray ScannerApril 10, 2024As an important tool in modern biotechnology, DNA microarray scanners play a vital role in genomics, disease diagnosis, drug research and development, and other fields. They can achieve rapid and accu...view
Why Do You Need Chromosomal Microarray Analysis?April 4, 2023Chromosomes are genetic material and the carriers of genes. The human body has 23 pairs of chromosomes, with 22 pairs being common to both sexes and called autosomes. The other pair determines sex and...view
The Power of Semiconductor Sequencing for High-Resolution CNV DetectionApril 8, 2024Unveiling the Genomic Landscape for CNV Detection (Semiconductor Sequencing & CNV Detection)Unlike traditional methods with limited resolution, semiconductor sequencing offers a high-throughput ap...view
Diagnosis of Colorectal Cancer from Three AspectsApril 4, 2023Coloretal cancer is a common digestive tract tumor with high malignancy. If it is not detected timely, the patient's condition is usually already in the middle or late stages. There are three main...view
The Role of Microfluidic Platforms in Drug Development and TestingJuly 18, 2024In the dynamic landscape of drug development and testing, the advent of microfluidic technology stands as a revolutionary advancement. Among the frontrunners in this innovation is CapitalBio, a brand ...view
Revolutionizing Molecular Diagnostics: CapitalBio’s Integration of Life Science Instruments and Sequencing TechnologiesApril 8, 2024Introduction to Life Science InstrumentThe life sciences field is witnessing an unprecedented transformation, thanks to the integration of sophisticated life science instruments. CapitalBio, a pioneer...view